logo
Share SHARE
FONT-SIZE Plus   Neg

Mylan, Pfizer Announce Epinephrine Auto-injector Settlement Agreement With Teva

Mylan Inc. (MYL: Quote) said Meridian Medical Technologies, a Pfizer (PFE: Quote) subsidiary, has entered into a settlement agreement with Teva (TEVA: Quote) that will resolve pending patent litigation related to its abbreviated new drug application for a generic epinephrine auto-injector.

According to the settlement terms, Teva may launch a generic epinephrine auto-injector covered by its ANDA on June 22, 2015 or earlier under certain circumstances, subject to receipt of approval from the U.S. Food and Drug Administration. Teva currently does not have tentative approval from the FDA for its epinephrine auto-injector product.

by RTT Staff Writer

For comments and feedback: editorial@rttnews.com

Business News

Editors Pick
Apple Watch is expected to post robust sales in the first weekend after its launch on April 24. A craze for Apple Watch may catapult the smartwatch industry into a lucrative market, while a not-so-impressive response for the Apple device may weigh on the industry. Fast food giant McDonald's Corp. (MCD), in a bid to boost slowing sales, is all set to make changes to its grilled chicken recipe by removing ingredients that may sound like chemicals to customers. The news was first reported by Associated Press, which said the new Artisan Grilled Chicken will no... GoDaddy Inc (GDDY) shares surged in its debut on the New York Stock Exchange following a successful initial public offering. GoDaddy, a technology provider dedicated to small businesses, priced its IPO of 23 million Class A shares at $20.00 each, above its estimated range of $17 to $19 per share. All...
comments powered by Disqus
RELATED NEWS
Trade PFE now with 
Follow RTT